EMA Authorised: Emtricitabine / Tenofovir alafenamide Viatris (emtricitabine;tenofovir alafenamide fumarate) — Viatris Limited

View source ↗

Summary

EMA authorised a fixed-dose combination antiretroviral therapy (emtricitabine/tenofovir alafenamide) by Viatris Limited for HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine / Tenofovir alafenamide Viatris (emtricitabine; tenofovir alafenamide fumarate)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 16/04/2026